(SYRS) Syros Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Syros Pharmaceuticals | (SYRS) share price targets
Complete technical analysis of Syros Pharmaceuticals (SYRS) by charts plus indicators, forecast predictions and share price targets for Syros Pharmaceuticals (SYRS)
Syros Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-13 View latest technical analysis
10 day averaged volume of Syros Pharmaceuticals is 1304050
Date | Daily Closing Price | Open | High | Low | Volume |
13 Thu Feb 2025 | 0.18 | 0.18 | 0.19 | 0.17 | 0.88 times |
12 Wed Feb 2025 | 0.18 | 0.17 | 0.19 | 0.17 | 2.631 times |
11 Tue Feb 2025 | 0.17 | 0.17 | 0.18 | 0.17 | 1.212 times |
10 Mon Feb 2025 | 0.17 | 0.18 | 0.18 | 0.16 | 0.681 times |
07 Fri Feb 2025 | 0.17 | 0.18 | 0.18 | 0.17 | 0.624 times |
06 Thu Feb 2025 | 0.18 | 0.18 | 0.19 | 0.17 | 1.04 times |
05 Wed Feb 2025 | 0.18 | 0.17 | 0.19 | 0.17 | 0.695 times |
04 Tue Feb 2025 | 0.17 | 0.17 | 0.17 | 0.16 | 0.435 times |
03 Mon Feb 2025 | 0.17 | 0.18 | 0.18 | 0.16 | 0.748 times |
31 Fri Jan 2025 | 0.18 | 0.17 | 0.18 | 0.17 | 0.778 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 0.2, but if it comes above 0.2, then a intra day buy could be more profitable.
If you take a sell trade below 0.2, then use 0.2 as stoploss and 0.2 as target. However if you take a buy trade in stock , then use 0.2 as stoploss and 0.19 as target.
Share price targets for Syros Pharmaceuticals (SYRS)
Target Type | Value |
Downside Target | 0.16 |
Downside Target | 0.18 |
Upside Target | 0.19 |
Upside Target | 0.20 |
Upside Target | 0.21 |
Upside Target | 0.23 |
Upside Target | 0.28 |
Upside Target | 0.31 |
Upside Target | 1.82 |
Upside Target | 2.77 |
Upside Target | 3.40 |
Intraday share price targets for Syros Pharmaceuticals (SYRS)
Target Type | Value |
Downside Intraday Target | 0.16 |
Downside Intraday Target | 0.15 |
Upside Intraday Target | 0.19 |
Upside Intraday Target | 0.21 |
Downside Intraday Target | 0.18 |
Weekly technical analysis of Syros Pharmaceuticals (SYRS)
Date | Weekly Closing Price | Open | High | Low | Volume |
13 Thu Feb 2025 | 0.18 | 0.18 | 0.19 | 0.16 | 1.526 times |
07 Fri Feb 2025 | 0.17 | 0.18 | 0.19 | 0.16 | 0.961 times |
31 Fri Jan 2025 | 0.18 | 0.20 | 0.21 | 0.16 | 1.293 times |
24 Fri Jan 2025 | 0.21 | 0.22 | 0.23 | 0.20 | 3.149 times |
17 Fri Jan 2025 | 0.22 | 0.21 | 0.23 | 0.21 | 0.151 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Syros Pharmaceuticals (SYRS)
Date | Monthly Closing Price | Open | High | Low | Volume |
13 Thu Feb 2025 | 0.18 | 0.18 | 0.19 | 0.16 | 0.294 times |
31 Fri Jan 2025 | 0.18 | 0.24 | 0.28 | 0.16 | 0.789 times |
31 Tue Dec 2024 | 0.23 | 0.24 | 0.31 | 0.19 | 0.102 times |
26 Tue Nov 2024 | 0.25 | 2.07 | 3.40 | 0.18 | 54.935 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Syros Pharmaceuticals (SYRS)
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Syros Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Syros Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Syros Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Syros Pharmaceuticals in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Syros Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.18 and Syros Pharmaceuticals (SYRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Syros Pharmaceuticals (SYRS) stock. Volume based technical analysis of Syros Pharmaceuticals (SYRS) stock is negative.
Syros Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Syros Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Syros Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Syros Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Syros Pharmaceuticals in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Syros Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.18 and Syros Pharmaceuticals (SYRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Syros Pharmaceuticals (SYRS) stock. Volume based technical analysis of Syros Pharmaceuticals (SYRS) stock is negative.
Syros Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.